GREG CUNY to Myositis Ossificans
This is a "connection" page, showing publications GREG CUNY has written about Myositis Ossificans.
Connection Strength
0.139
-
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants. J Med Chem. 2014 Oct 09; 57(19):7900-15.
Score: 0.119
-
BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008 Dec; 14(12):1363-9.
Score: 0.020